CONTINENTAL ADVISORS LLC

Position in VTRS — Viatris Inc

CIK 1277779 Park City, UT

Back to VTRS Full portfolio

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,007,012

+$707,542 QoQ

Shares Held

888,750

-2.1% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

7.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

22 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Derivatives in VTRS

reported options exposure · as of Mar 31, 2026

CallValue

$630,917

CallShares

46,700

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CONTINENTAL ADVISORS LLC holds $23,793,973 across 3 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (50.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc This page	888,750	$12,007,012
2	TEVA	Teva Pharmaceutical Industries Ltd	242,118	$7,292,594
3	PRGO	PERRIGO Co plc	418,470	$4,494,367

All Filings in VTRS

Export CSV

43 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,007,012	888,750	+1803.1%	Shares	Sole	2026-05-15
2026-03-31	$630,917	46,700	-94.9%	Call	Sole	2026-05-15
2025-12-31	$11,299,470	907,588	+394.1%	Shares	Sole	2026-02-12
2025-12-31	$2,287,065	183,700	-80.7%	Call	Sole	2026-02-12
2025-09-30	$9,420,721	951,588	+128.2%	Shares	Sole	2025-11-03
2025-09-30	$4,128,300	417,000	-24.0%	Call	Sole	2025-11-03
2025-06-30	$4,902,570	549,000	-44.2%	Call	Sole	2025-08-19
2025-06-30	$8,790,959	984,430	+36.0%	Shares	Sole	2025-08-19
2025-03-31	$6,306,040	724,000	-23.3%	Call	Sole	2025-05-16
2025-03-31	$8,225,985	944,430	+70.8%	Shares	Sole	2025-05-16
2024-12-31	$6,886,095	553,100	-26.3%	Call	Sole	2025-02-14
2024-12-31	$9,348,804	750,908	-4.3%	Shares	Sole	2025-02-14
2024-09-30	$9,112,561	784,889	+57.3%	Shares	Sole	2024-11-14
2024-09-30	$5,793,390	499,000	-38.5%	Call	Sole	2024-11-14
2024-06-30	$8,619,750	810,889	+76.7%	Shares	Sole	2024-08-14
2024-06-30	$4,879,170	459,000	-17.5%	Call	Sole	2024-08-14
2024-03-31	$6,640,896	556,189	-5.4%	Shares	Sole	2024-05-15
2024-03-31	$7,020,720	588,000	-17.9%	Call	Sole	2024-05-15
2023-12-31	$7,759,695	716,500	+19.8%	Call	Sole	2024-02-14
2023-12-31	$6,475,137	597,889	-5.3%	Shares	Sole	2024-02-14
2023-09-30	$6,225,495	631,389	+43.5%	Shares	Sole	2023-11-14
2023-09-30	$4,339,386	440,100	-36.3%	Call	Sole	2023-11-14
2023-06-30	$6,895,072	690,889	+192.6%	Shares	Sole	2023-08-14
2023-06-30	$2,356,278	236,100	+257.2%	Call	Sole	2023-08-14
2023-03-31	$635,882	66,100	-90.4%	Call	Sole	2023-05-15
2023-03-31	$6,646,352	690,889	+62.3%	Shares	Sole	2023-05-15
2022-12-31	$4,739,031	425,789	-22.9%	Shares	Sole	2023-02-14
2022-12-31	$6,147,099	552,300	-11.5%	Call	Sole	2023-02-14
2022-09-30	$5,317,332	624,100	-3.4%	Call	Sole	2022-11-14
2022-09-30	$5,503,093	645,903	-1.9%	Shares	Sole	2022-11-14
2022-06-30	$6,893,479	658,403	+364.0%	Shares	Sole	2022-08-15
2022-06-30	$1,485,693	141,900	-79.0%	Call	Sole	2022-08-15
2022-03-31	$7,348,384	675,403	+106.4%	Shares	Sole	2022-05-16
2022-03-31	$3,559,936	327,200	-41.5%	Call	Sole	2022-05-16
2021-12-31	$7,568,722	559,403	+194.0%	Shares	Sole	2022-02-14
2021-12-31	$2,574,759	190,300	-28.0%	Call	Sole	2022-02-14
2021-09-30	$3,582,620	264,400	-48.8%	Call	Sole	2021-11-15
2021-09-30	$7,002,680	516,803	+5.5%	Shares	Sole	2021-11-15
2021-06-30	$7,000,956	489,920	+121.9%	Shares	Sole	2021-08-16
2021-03-31	$3,084,576	220,800	-48.1%	Call	Sole	2021-05-17
2021-03-31	$5,943,117	425,420	+750.8%	Shares	Sole	2021-05-17
2020-12-31	$937,000	50,000	-81.6%	Call	Sole	2021-02-16
2020-12-31	$5,092,032	271,720	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.